Membrane permeation induced by aggregates of human islet amyloid polypeptides.

Several neurodegenerative diseases such as Alzheimer's and Parkinson's diseases as well as nonneuropathic diseases such as type II diabetes and atrial amyloidosis are associated with aggregation of amyloid polypeptides into fibrillar structures, or plaques. In this study, we use molecular dynamics simulations to test the stability and orientation of membrane-embedded aggregates of the human islet amyloid polypeptide (hIAPP) implicated in type II diabetes. We find that in both monolayers and bilayers of dipalmitoylphosphatidylglycerol (DPPG) hIAPP trimers and tetramers remain inside the membranes and preserve their β-sheet secondary structure. Lipid bilayer-inserted hIAPP trimers and tetramers orient inside DPPG at 60° relative to the membrane/water interface and lead to water permeation and Na(+) intrusion, consistent with ion-toxicity in islet β-cells. In particular, hIAPP trimers form a water-filled β-sandwich that induce water permeability comparable with channel-forming proteins, such as aquaporins and gramicidin-A. The predicted disruptive orientation is consistent with the amphiphilic properties of the hIAPP aggregates and could be probed by chiral sum frequency generation (SFG) spectroscopy, as predicted by the simulated SFG spectra.

[1]  William J. Allen,et al.  GridMAT‐MD: A grid‐based membrane analysis tool for use with molecular dynamics , 2009, J. Comput. Chem..

[2]  P E Fraser,et al.  Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. , 2001, Journal of molecular biology.

[3]  M. Kirkitadze,et al.  Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies , 2002, Journal of neuroscience research.

[4]  D. Wales,et al.  Transmembrane structures for Alzheimer's Aβ(1-42) oligomers. , 2010, Journal of the American Chemical Society.

[5]  R. Kayed,et al.  Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.

[6]  T. Piggot,et al.  Electroporation of the E. coli and S. Aureus membranes: molecular dynamics simulations of complex bacterial membranes. , 2011, The journal of physical chemistry. B.

[7]  N. Eberhardt,et al.  Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells. , 1999, The American journal of pathology.

[8]  P. Pieniazek,et al.  Interpretation of the water surface vibrational sum-frequency spectrum. , 2011, The Journal of chemical physics.

[9]  Bruce A. Yankner,et al.  Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus , 1994, Nature.

[10]  S. Radford,et al.  Structural insights into the polymorphism of amyloid-like fibrils formed by region 20-29 of amylin revealed by solid-state NMR and X-ray fiber diffraction. , 2008, Journal of the American Chemical Society.

[11]  Johannes D. Veldhuis,et al.  Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets , 2007, Diabetes.

[12]  José Mario Martínez,et al.  PACKMOL: A package for building initial configurations for molecular dynamics simulations , 2009, J. Comput. Chem..

[13]  Maarten F. M. Engel,et al.  The role of the disulfide bond in the interaction of islet amyloid polypeptide with membranes , 2010, European Biophysics Journal.

[14]  Ruth Nussinov,et al.  Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link. , 2011, Biophysical journal.

[15]  R. Larson,et al.  Simulations of zwitterionic and anionic phospholipid monolayers. , 2002, Biophysical journal.

[16]  Oliver Beckstein,et al.  The influence of geometry, surface character, and flexibility on the permeation of ions and water through biological pores , 2004, Physical biology.

[17]  B. L. de Groot,et al.  Potentials of mean force and permeabilities for carbon dioxide, ammonia, and water flux across a Rhesus protein channel and lipid membranes. , 2010, Journal of the American Chemical Society.

[18]  H. Lashuel,et al.  Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. , 2010, Angewandte Chemie.

[19]  C. Betsholtz,et al.  Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Hai Lin,et al.  Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Ruth Nussinov,et al.  Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology. , 2012, The journal of physical chemistry. B.

[22]  R. Pastor,et al.  Computer simulation of liquid/liquid interfaces. II. Surface tension-area dependence of a bilayer and monolayer , 1995 .

[23]  A. Watts,et al.  Membrane thickening by the antimicrobial peptide PGLa. , 2008, Biophysical journal.

[24]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[25]  Ruth Nussinov,et al.  Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. , 2007, Biophysical journal.

[26]  B. Strodel,et al.  Stability of Transmembrane Amyloid β-Peptide and Membrane Integrity Tested by Molecular Modeling of Site-Specific Aβ 42 Mutations , 2013, PloS one.

[27]  R. Nussinov,et al.  New structures help the modeling of toxic amyloidbeta ion channels. , 2008, Trends in biochemical sciences.

[28]  Ruth Nussinov,et al.  Stabilities and conformations of Alzheimer's beta -amyloid peptide oligomers (Abeta 16-22, Abeta 16-35, and Abeta 10-35): Sequence effects. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Kukol,et al.  How the amyloid-β peptide and membranes affect each other: an extensive simulation study. , 2013, Biochimica et biophysica acta.

[30]  Helmut Grubmüller,et al.  Dynamics and energetics of permeation through aquaporins. What do we learn from molecular dynamics simulations? , 2009, Handbook of experimental pharmacology.

[31]  Christian Kandt,et al.  Setting up and running molecular dynamics simulations of membrane proteins. , 2007, Methods.

[32]  S. Jayasinghe,et al.  Lipid membranes modulate the structure of islet amyloid polypeptide. , 2005, Biochemistry.

[33]  B. Kagan,et al.  Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*) , 1996, The Journal of Biological Chemistry.

[34]  W. Shinoda,et al.  Cholesterol effect on water permeability through DPPC and PSM lipid bilayers: a molecular dynamics study. , 2011, The journal of physical chemistry. B.

[35]  R. Nussinov,et al.  Probing Structural Features of Alzheimer’s Amyloid-β Pores in Bilayers Using Site-Specific Amino Acid Substitutions , 2012, Biochemistry.

[36]  Maarten F. M. Engel,et al.  Islet amyloid polypeptide inserts into phospholipid monolayers as monomer. , 2006, Journal of molecular biology.

[37]  M. Stefani,et al.  Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity , 2010, The FEBS journal.

[38]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[39]  Shaul Mukamel,et al.  Vibrational sum-frequency generation spectroscopy at the water/lipid interface: molecular dynamics simulation study. , 2010, Journal of the American Chemical Society.

[40]  A. Miranker,et al.  Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. , 2006, Biochemistry.

[41]  Chris Oostenbrink,et al.  A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..

[42]  R. Nussinov,et al.  Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ16–22, Aβ16–35, and Aβ10–35): Sequence effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Holman,et al.  Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. , 1988, Diabetes research.

[44]  U Aebi,et al.  Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.

[45]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[46]  Ralf Langen,et al.  Identifying Structural Features of Fibrillar Islet Amyloid Polypeptide Using Site-directed Spin Labeling* , 2004, Journal of Biological Chemistry.

[47]  S. Kahn,et al.  Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. , 1999, Diabetes.

[48]  D. Harrison,et al.  The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. , 1999, Diabetes.

[49]  Elsa C. Y. Yan,et al.  Amphiphilic adsorption of human islet amyloid polypeptide aggregates to lipid/aqueous interfaces. , 2012, Journal of molecular biology.

[50]  Yen Sun,et al.  How type II diabetes-related islet amyloid polypeptide damages lipid bilayers. , 2012, Biophysical journal.

[51]  D. Tieleman,et al.  Molecular view of phase coexistence in lipid monolayers. , 2012, Journal of the American Chemical Society.

[52]  N. Eberhardt,et al.  Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis. , 1995, The American journal of pathology.

[53]  K. R. Jeffrey,et al.  Molecular dynamics simulations and 2H NMR study of the GalCer/DPPG lipid bilayer. , 2005, Biophysical journal.

[54]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[55]  Garth J. Simpson,et al.  A Unified Treatment of Selection Rules and Symmetry Relations for Sum-Frequency and Second Harmonic Spectroscopies , 2004 .

[56]  P. Lansbury,et al.  Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. , 2002, Biochemistry.

[57]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[58]  Maarten F. M. Engel,et al.  Islet amyloid polypeptide‐induced membrane leakage involves uptake of lipids by forming amyloid fibers , 2004, FEBS letters.

[59]  Per Westermark,et al.  Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[60]  R. Nussinov,et al.  All-d-Enantiomer of β-Amyloid Peptide Forms Ion Channels in Lipid Bilayers , 2012, Journal of chemical theory and computation.

[61]  A. Meister,et al.  Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. , 2007, Biophysical journal.

[62]  E. D. de Koning,et al.  Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice , 1994, Journal of cellular biochemistry.

[63]  Michael W. Schwartz,et al.  Evidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells , 1990, Diabetes.

[64]  Shuanghong Huo,et al.  Conformations of Islet Amyloid Polypeptide Monomers in a Membrane Environment: Implications for Fibril Formation , 2012, PloS one.

[65]  A. Morita,et al.  Analysis of anisotropic local field in sum frequency generation spectroscopy with the charge response kernel water model. , 2009, The Journal of chemical physics.

[66]  A. Miranker,et al.  Phospholipid catalysis of diabetic amyloid assembly. , 2004, Journal of molecular biology.

[67]  D. Teplow,et al.  Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease , 2004, Neurobiology of Aging.

[68]  Thomas L. Williams,et al.  Membrane and surface interactions of Alzheimer’s Aβ peptide – insights into the mechanism of cytotoxicity , 2011, The FEBS journal.

[69]  Kevin Hartman,et al.  A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. , 2008, Biochemistry.

[70]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[71]  Guanghong Wei,et al.  Lipid Interaction and Membrane Perturbation of Human Islet Amyloid Polypeptide Monomer and Dimer by Molecular Dynamics Simulations , 2012, PloS one.

[72]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[73]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[74]  R. Nussinov,et al.  Misfolded amyloid ion channels present mobile beta-sheet subunits in contrast to conventional ion channels. , 2009, Biophysical journal.

[75]  E. Gazit,et al.  The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. , 2003, Biochemistry.

[76]  Richard Leapman,et al.  Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. , 2007, Biochemistry.

[77]  R. Nussinov,et al.  Polymorphism of amyloid β peptide in different environments: implications for membrane insertion and pore formation. , 2011, Soft matter.

[78]  X. Daura,et al.  Peptide Folding: When Simulation Meets Experiment , 1999 .

[79]  Ruth Nussinov,et al.  Probing ion channel activity of human islet amyloid polypeptide (amylin). , 2012, Biochimica et biophysica acta.